CVS Health (CVS) said Monday it has appointed four board members following "productive discussions" with Glenview Capital Management.
The company said it added Leslie Norwalk, Larry Robbins, Guy Sansone and Doug Shulman to the board, bringing its total members to 16.
Norwalk is a strategic counsel to various health care companies; Robbins is the founder and chief executive of Glenview Capital Management; Sansone is the chairman and CEO of H2 Health, and Shulman is the chairman of OneMain Holdings.
In connection with the appointments, the company said it has entered into a confidentiality agreement with Glenview, wherein the latter agreed to customary confidentiality, standstill and other provisions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。